HIMS three-lens brief
Evidence-based stock research on HIMS. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 13.7pp over 30 days. · Debt-to-equity of 207.2 — balance-sheet-heavy.
- Outperforming SPY by 13.7pp over 30 days.
- Debt-to-equity of 207.2 — balance-sheet-heavy.
HIMS closed at $27.50 (+0.33%) as of 2026-05-04. Market cap: $6.35B. P/E (trailing) 53.9. Positives: outperforming SPY by 13.7pp over 30 days.. Concerns: debt-to-equity of 207.2 — balance-sheet-heavy.. Last quarter: Revenue $617.82M, net income $20.60M, free cash flow $110.51M.
Why three lenses on HIMS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine HIMSacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/HIMS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath HIMS brief"></iframe>